# New fibrosis clinical trials, last 30 days: 22 (2026)

Updated November 19, 2026.

22 new trials for fibrosis were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New fibrosis clinical trials, last 30 days: 22 rows for $5, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/new/fibrosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 19
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944183 | The PRECISION Partners Platform (P3) Study | Imperial College London | Observational | Recruiting | Cystic Fibrosis (CF), Chronic Suppurative Lung Disease, Primary Ciliary Dyskinesia (PCD), Bronchiectasis, Healthy... | 850 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944183) |
| November 17, 2026 | NCT07942428 | Enzymatic Treatment for Postoperative Nasal Fibrosis After Rhinoplasty | Research Inc | Not applicable | Recruiting | Postoperative Nasal Fibrosis After Rhinoplasty | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942428) |
| November 12, 2026 | NCT07933328 | Study to Evaluate ALN-CIDEB in Adults With Fibrotic Alcohol-Associated Liver Disease (ALD) | Regeneron Pharmaceuticals | Phase 2 | Not yet recruiting | Alcohol-Associated Liver Disease, ALD | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933328) |
| November 12, 2026 | NCT07933133 | A Multicenter, Randomized, Blinded, Placebo- and Active-Controlled Phase II Study to Evaluate the Efficacy and Safety of SYH9061 in Adult... | CSPC-NBP Pharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07933133) |
| November 12, 2026 | NCT07930221 | The Effects of Yoga Practice on Exercise Capacity, Arterial Stiffness, Respiratory Function, Peripheral Muscle Strength, Posture and... | Hacettepe University | Not applicable | Recruiting | Cystic Fibrosis (CF) | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930221) |
| November 10, 2026 | NCT07929948 | A Phase Ⅱa Study of ND-003 Tablets in Patients With Idiopathic Pulmonary Fibrosis | Shenzhen NewDEL Biotech, Co., Ltd | Phase 2 | Enrolling by invitation | Idiopathic Pulmonary Fibrosis (IPF) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929948) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 6, 2026 | NCT07921082 | Effectiveness of Oxitard Gel Versus Physiotherapeutic and Pharmacological Interventions in Alleviating Oral Submucous Fibrosis: A Phase-II... | Dow University of Health Sciences | Phase 2 | Not yet recruiting | Oral and Maxillofacial Conditions | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07921082) |
| November 5, 2026 | NCT07919015 | Real-world Study of Nerandomilast in Patients With Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis | Sponsor not shown (see the record) | Observational | Recruiting | Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919015) |
| November 5, 2026 | NCT07918378 | Treatment Outcomes and Predictors After Endovascular Intervention for Portal Hypertension-Related Gastrointestinal Bleeding in Cirrhosis | University Medical Center Ho Chi Minh City (UMC) | Observational | Recruiting | Cirrhosis, Portal Hypertension Related to Cirrhosis, GI Bleeding, Gastrointestinal Bleeding | 167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918378) |
| November 3, 2026 | NCT07914504 | Autologous PRP Versus Triamcinolone Acetate in Patients With Oral Submucous Fibrosis | Allama Iqbal Medical College | Not applicable | Not yet recruiting | Oral Submucous Fibrosis | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914504) |
| November 2, 2026 | NCT07909655 | A Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis | Shanghai Huaota Biopharmaceutical Co., Ltd. | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis (IPF) | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909655) |
| October 29, 2026 | NCT07904325 | Vascular Health and Function in Cystic Fibrosis | Liverpool Heart and Chest Hospital NHS Foundation Trust | Observational | Not yet recruiting | Cystic Fibrosis, Endothelial Dysfunction, Cardiovascular Risk Factor | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07904325) |
| October 29, 2026 | NCT07903792 | Diagnostic Value of Oropharyngeal Suction and Effect of Respiratory Physiotherapy on the Detection of Microorganisms in the Pediatric... | Corporacion Parc Tauli | Not applicable | Recruiting | Cystic Fibrosis (CF), Bronchiectasis, Non-Cystic Fibrosis | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903792) |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |
| October 26, 2026 | NCT07895108 | Assessment of Static and Dynamic Inspiratory Muscle Strength and Cardiorespiratory Fitness in Adults With Cystic Fibrosis | Hacettepe University | Observational | Completed | Cystic Fibrosis (CF), Cardiorespiratory Fitness, Inspiratory Muscle Strength | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895108) |
| October 23, 2026 | NCT07892443 | Type 2 Inflammation in Adults With Cystic Fibrosis | University of Virginia | Observational | Not yet recruiting | Cystic Fibrosis (CF), Type 2 Inflammatory Disorders | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892443) |
| October 23, 2026 | NCT07891130 | Curcumin Plus Topical Steroid Versus Topical Steroid Alone for Oral Submucous Fibrosis | Liaquat College of Medicine and Dentistry | Not applicable | Completed | Oral Submucous Fibrosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07891130) |
| October 22, 2026 | NCT07890766 | Management of Breast Fibroadenoma: Comparing Observation, Microwave Ablation, and Surgical Excision | Sohag University | Not applicable | Not yet recruiting | Fibroadenoma, Breast Fibroadenoma, Benign Breast Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890766) |
| October 22, 2026 | NCT07889973 | A Precision Medicine Approach to Assess Protein Function Loss and the Potential for CFTR Function Restoration in Cystic Fibrosis and... | Istituto Giannina Gaslini | Observational | Recruiting | Cystic Fibrosis (CF) | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889973) |
| October 22, 2026 | NCT07889726 | "Anticipant"-TIPS After a First Portal-hypertension-related Complication in Cirrhosis | University Hospital, Toulouse | Not applicable | Not yet recruiting | Cirrhosis | 266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889726) |
| October 21, 2026 | NCT07885410 | PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment | Fondation Ildys | Observational | Recruiting | Cystic Fibrosis (CF) | 343 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07885410) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 6 |
| Phase 4 | 1 |
| Not applicable | 7 |
| Observational | 8 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| Hacettepe University | 2 |
| Imperial College London | 1 |
| [Research Inc](https://specstream.ai/data/clinical-trials/company/research-inc) | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| CSPC-NBP Pharmaceutical Co., Ltd. | 1 |
| Shenzhen NewDEL Biotech, Co., Ltd | 1 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 1 |
| Dow University of Health Sciences | 1 |
| University Medical Center Ho Chi Minh City (UMC) | 1 |
| Allama Iqbal Medical College | 1 |
| Shanghai Huaota Biopharmaceutical Co., Ltd. | 1 |
| Liverpool Heart and Chest Hospital NHS Foundation Trust | 1 |
| Corporacion Parc Tauli | 1 |
| University of Michigan | 1 |
| University of Virginia | 1 |
| Liaquat College of Medicine and Dentistry | 1 |
| Sohag University | 1 |
| Istituto Giannina Gaslini | 1 |
| University Hospital, Toulouse | 1 |
| Fondation Ildys | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Clothing companies in the United States](https://specstream.ai/data/businesses/clothing-companies/united-states)
- [Logging contractors in the United States](https://specstream.ai/data/businesses/logging-contractors/united-states)
- [Truck rental companies in the United States](https://specstream.ai/data/businesses/truck-rental-companies/united-states)
- [Distilleries in the United States](https://specstream.ai/data/businesses/distilleries/united-states)
- [Nicaraguan restaurants in the United States](https://specstream.ai/data/businesses/nicaraguan-restaurants/united-states)
- [Women's health clinics in the United States](https://specstream.ai/data/businesses/womens-health-clinics/united-states)
